PHENYephrine HCl in 0.9% Sodium Chloride (PF) (Contains Sulfites). 30 mg/250 mL (0.12 mg/mL), 25...

FDA Drug Recall #D-0089-2020 — Class II — September 12, 2019

Recall Summary

Recall Number D-0089-2020
Classification Class II — Moderate risk
Date Initiated September 12, 2019
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm KRS Global Biotechnology, Inc
Location Boca Raton, FL
Product Type Drugs
Quantity 60 bags

Product Description

PHENYephrine HCl in 0.9% Sodium Chloride (PF) (Contains Sulfites). 30 mg/250 mL (0.12 mg/mL), 250 mL Single-Dose Bag For IV Infusion Use, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321678401

Reason for Recall

Lack of Assurance of Sterility

Distribution Pattern

Nationwide

Lot / Code Information

All lots remaining within expiry.

Other Recalls from KRS Global Biotechnology, Inc

Recall # Classification Product Date
D-0114-2020 Class II Vitamin 9A/B Lyophilized, Vial For IM Use, Rx O... Sep 12, 2019
D-0054-2020 Class II GLYCOpyrrolate (PF) 0.6 mg/3 mL (0.2 mg/mL) in ... Sep 12, 2019
D-0100-2020 Class II Sermorelin, 3 mg / GHRP-2, 3 mg / Vial, For SC ... Sep 12, 2019
D-0078-2020 Class II NEOstigmine Methylsulfate (PF), 5 mg/5 mL (1 mg... Sep 12, 2019
D-0092-2020 Class II Quadmix # 19 (Prostaglandin E1-0.75 mg / Papave... Sep 12, 2019

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.